glp-1 agonist oral Receptor Agonists: The New Wave in Diabetes Management GLP-1 Agonists For Obesity In

Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies

If youve heard about GLP-1 medications like Wegovy, Zepbound,or Saxenda, you know they help people lose weight by reducing appetite and slowing digestion

Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

GLP-1 weight loss drugs are reshaping US food consumption, reducing snack intake and driving industry shifts in nutrition, labels and product innovation.